MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS

World News: . []

LA JOLLA Calif April 15 2019 GLOBE NEWSWIRE -- MediciNova Inc a biopharmaceutical company traded on the NASDAQ Global Market Nasdaq MNOV and the JASDAQ Market of the Tokyo Stock Exchange Code Number 4875 today announced that the U S. Food...

More news and information about MediciNova, Inc.

Published By:

Globe Newswire: 00:00 GMT Tuesday 16th April 2019

Published: .

Search for other references to "medicinova" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us